| 2005 |
Tbr2/EOMES expression defines the intermediate progenitor cell (IPC) stage in neocortical neurogenesis, marking the transition from Pax6+ radial glia to Tbr2+ IPCs to Tbr1+ postmitotic neurons, establishing a sequential transcription factor cascade Pax6 → Tbr2 → Tbr1 in the differentiation of radial glia → intermediate progenitor cell → postmitotic projection neuron. |
Immunohistochemistry, in situ hybridization, cell-type-specific marker co-expression in developing mouse neocortex |
The Journal of neuroscience |
High |
15634788
|
| 2008 |
Conditional ablation of Tbr2/EOMES in the developing forebrain results in loss of intermediate progenitor cells (IPCs) and their neuronal progeny, reduced cortical surface expansion and thickness, and neuronal reduction across all cortical layers. Conversely, misexpression of Tbr2 in ventricular radial glial cells is sufficient to induce IPC identity, demonstrating Tbr2 is both necessary and sufficient for IPC specification. |
Conditional knockout mouse (forebrain-specific Tbr2 ablation), Tbr2::GFP transgenic cell fate tracing, gain-of-function misexpression |
Neuron |
High |
18940588
|
| 2008 |
Tbr2/EOMES protein is specifically localized to intermediate-stage progenitor cells (IPCs) in the adult mouse hippocampus (subgranular zone), and Tbr2+ IPCs are highly responsive to neurogenic stimuli (voluntary wheel running more than doubles their number), establishing Tbr2 as a marker of transit-amplifying cells in adult hippocampal neurogenesis operating within the same Pax6 → Ngn2 → Tbr2 → NeuroD → Tbr1 transcription factor cascade as embryonic cortex. |
Immunostaining, Tbr2-GFP transgene expression, BrdU/antimitotic drug manipulation, multi-TF cascade analysis in adult mouse brain |
The Journal of neuroscience |
High |
18385329
|
| 2008 |
Ngn2 directly activates Tbr2 transcription in nascent neocortical daughter cells; Notch signaling in periventricular daughter cells suppresses this Ngn2-Tbr2 cascade. Tbr2 expression is initiated asymmetrically in one of the two daughter cells following radial glial division, biased toward the apical cell. |
Single-cell DiI labeling and time-lapse tracking in slice cultures, immunostaining, gamma-secretase inhibition, identification of Tbr2 as direct Ngn2 target |
Molecular and cellular neurosciences |
Medium |
19059340
|
| 2010 |
Tbr2-positive cortical intermediate progenitors control the amount and migratory route of subpallial GABAergic interneurons into the subventricular zone through a non-cell-autonomous mechanism mediated by Cxcl12 chemokine signaling. Forced Cxcl12 expression in Tbr2 mutants partially rescues SVZ interneuron migration, placing Tbr2 upstream of Cxcl12 in coordinating excitatory and inhibitory neuron balance. |
Tbr2 conditional knockout, interneuron migration analysis, Cxcl12 rescue experiment in mutant cortex |
Genes & development |
High |
20713522
|
| 2010 |
EOMES co-occupies a significant number of genomic loci with TCFAP2C and SMARCA4 in trophoblast stem (TS) cells as determined by ChIP-chip. RNAi depletion of Eomes leads to loss of normal TS cell colony morphology and downregulation of TS cell-specific genes, establishing EOMES as a component of the transcriptional network required for TS cell self-renewal. |
ChIP-chip (chromatin immunoprecipitation with microarray), RNAi knockdown, transcriptome analysis in mouse trophoblast stem cells |
Genome research |
High |
20176728
|
| 2012 |
Mice lacking both Eomes and T-bet fail to develop NK cells. Eomes is specifically required for the maturation step characterized by loss of constitutive TRAIL expression and induction of Ly49 receptor diversity and CD49b (DX5+), while T-bet governs developmental stability of immature TRAIL+ NK cells. Deletion of Eomes from mature NK cells causes reversion to phenotypic immaturity. |
Eomes/T-bet double conditional knockout mice, NK cell developmental stage analysis by flow cytometry, genetic deletion of Eomes in mature NK cells |
Immunity |
High |
22261438
|
| 2012 |
Tbr2/EOMES is critically required for neurogenesis in the dentate gyrus: in the absence of Tbr2, intermediate neuronal progenitors (INPs) are depleted despite augmented neural stem cell proliferation, neurogenesis is halted due to failed neuronal differentiation, and Tbr2 likely promotes lineage progression from NSC to INP in part by repression of Sox2. |
Conditional Tbr2 knockout in mouse dentate gyrus, flow cytometry, immunostaining, Sox2 expression analysis |
The Journal of neuroscience |
High |
22553033
|
| 2013 |
Tbr2/EOMES is required for proper migration of Cajal-Retzius cells to the dentate gyrus (DG), formation of the hippocampal fissure, and establishment of the transhilar radial glial scaffold. Loss of Tbr2 results in decreased Cxcr4 expression in migrating cells, leading to premature granule neurogenesis and increased cell death, and depletes the DG stem cell population before proper SGZ establishment. |
Conditional Tbr2 knockout, cell migration analysis, Cxcr4 expression profiling, BrdU labeling in developing mouse dentate gyrus |
The Journal of neuroscience |
High |
23447624
|
| 2013 |
The histone demethylase Jmjd3 sequentially associates with Tbx3 (at the Eomes enhancer) and then with Eomes itself (at its own bivalent promoter) to drive Eomes expression during endodermal differentiation of embryonic stem cells. Eomes then activates a transcriptional network of core regulators of definitive endoderm differentiation, and Activin signaling promotes Jmjd3/Eomes binding at the Eomes promoter in a positive feedback loop. |
ChIP, chromatin conformation/looping analysis, Activin signaling perturbation, gene expression analysis in differentiating mouse ES cells |
The EMBO journal |
High |
23584530
|
| 2013 |
Eomes inactivation in the cortical subventricular zone causes rostrocaudal shifts in SVZ and CP gene expression gradients (the 'intermediate map'), with loss of corticospinal axons and gain of corticotectal projections, establishing Eomes as a modulator of regional identity propagation from VZ progenitors to cortical plate neurons via the Pax6 → Eomes → Tbr1 cascade. |
Conditional Eomes inactivation, in situ hybridization for regional markers, axonal tract tracing in mouse neocortex |
Proceedings of the National Academy of Sciences of the United States of America |
High |
23431145
|
| 2013 |
Tbr2 deficiency in olfactory bulb mitral and tufted cells causes cell-autonomous changes including compensatory upregulation of Tbr1 and VGluT subtype shift (VGluT1 to VGluT2), dendritic morphology and projection abnormalities, non-cell-autonomous loss of inhibitory interneuron subtypes, reduction in dendrodendritic reciprocal synapses, and hyperactivation of mitral/tufted cells by odorants—establishing Tbr2 as required for excitatory-inhibitory balance in the olfactory bulb. |
Conditional Tbr2 knockout in mitral/tufted cells, immunostaining, odorant stimulation/c-Fos analysis, electron microscopy for synapse counting |
The Journal of neuroscience |
High |
22745484
|
| 2014 |
E4bp4/Nfil3 directly binds to the regulatory regions of both Eomes and Id2 and promotes their transcription, acting upstream of Eomes in NK lineage commitment. Eomes and Id2 can rescue NK production from E4bp4-/- progenitors, placing Eomes downstream of E4bp4 in the NK development transcriptional hierarchy. |
ChIP, genetic rescue of E4bp4-/- NK progenitors with Eomes/Id2 overexpression, E4bp4 knockout mouse |
The Journal of experimental medicine |
High |
24663216
|
| 2014 |
In the liver, T-bet expression in progenitors represses Eomes expression and the development of Eomes+ NK cells. Conversely, the bone marrow microenvironment restricts T-bet expression in developing NK cells, permitting Eomes-dependent NK maturation. Ectopic expression of T-bet forces development of Eomes- NK cells, demonstrating that T-bet repression is essential for Eomes+ NK cell development. Eomes- and Eomes+ NK cells constitute distinct lineages with complementary functions. |
Eomes-GFP reporter mouse generation, ectopic T-bet expression, gene expression profiling, Eomes conditional knockout analysis |
The Journal of experimental medicine |
High |
24516120
|
| 2014 |
Tbr2/EOMES is essential for the formation and maintenance of melanopsin (Opn4)-expressing intrinsically photosensitive retinal ganglion cells (ipRGCs): Opn4 expression is exclusive to Tbr2+ RGCs, genetic ablation of Tbr2 before RGC specification eliminates all ipRGCs, and deletion of Tbr2 in established ipRGCs eliminates most of them and causes dendritic morphology defects. |
Conditional Tbr2 knockout (pre- and post-specification), single-cell dye tracing, behavioral analysis, immunostaining in mouse retina |
The Journal of neuroscience |
High |
25253855
|
| 2016 |
Eomes controls non-classic Th1 (Th17-derived Th1) cell development by promoting IFN-γ secretion while inhibiting ROR-γt expression and IL-17 production. In a mouse model of T cell-dependent colitis, Eomes drives non-classic Th1 pathogenic potential in vivo; Eomes also promotes acquisition of a cytotoxic signature and IFN-γ+GM-CSF+ cell development. |
Eomes overexpression/conditional knockout in colitis mouse model, flow cytometry, cytokine analysis, ROR-γt expression analysis |
European journal of immunology |
Medium |
30144030
|
| 2016 |
Foxo3 directly targets and activates the Eomes gene in CD4+ T cells. Lentiviral overexpression of Eomes in Foxo3-deficient CD4+ T cells restores IFN-γ and GM-CSF production, establishing a Foxo3-Eomes axis required for pathogenic Th1 cell differentiation and neuroinflammation. |
Foxo3 knockout mice, EAE model, lentiviral Eomes overexpression in Foxo3-deficient T cells, direct Eomes target gene identification |
Immunity |
High |
27742544
|
| 2017 |
TBR2 directly regulates a molecular network in intermediate neuronal progenitors (INPs) through protein-protein interactions with NEUROG2 and JMJD3, revealing both genetic and epigenetic mechanisms. Genome-wide ChIP-seq identified TBR2 direct target genes, and co-IP confirmed NEUROG2 and JMJD3 as TBR2 binding partners controlling INP identity, morphology, proliferation, and migration. |
ChIP-seq (TBR2 genome-wide binding), global gene expression profiling, co-immunoprecipitation, conditional knockout analysis in mouse cortex |
Cerebral cortex |
High |
27600842
|
| 2017 |
A visceral/primitive streak enhancer element (VPE) in the Eomes locus is required for optimal Eomes expression in vivo; deletion of VPE causes variable defects in anterior-posterior axis orientation and definitive endoderm formation. Chromosome conformation capture shows VPE-promoter interactions in ES cells prior to gene activation; activation during DE differentiation is associated with Smad2/3 binding and increased chromatin accessibility at VPE, occurring without large-scale 3D chromatin reorganization. |
Transgenic enhancer reporter assays, targeted enhancer deletion, chromosome conformation capture (3C/4C), ATAC-seq, Smad2/3 ChIP in mouse embryos and ES cells |
Development |
High |
28174238
|
| 2018 |
A lincRNA (linc1405) physically mediates a complex consisting of Eomes, TrxG subunit WDR5, and histone acetyltransferase GCN5 that binds the enhancer region of the Mesp1 gene to activate its expression during cardiac mesoderm specification of embryonic stem cells. Linc1405 depletion impairs heart development and function in vivo. |
Chromatin immunoprecipitation (ChIP), RNA immunoprecipitation (RIP), linc1405 knockdown in ESCs and in vivo zebrafish/mouse models |
Cell stem cell |
High |
29754779
|
| 2018 |
Dose-dependent induction of EOMES alone can fully replace a cocktail of signaling molecules for cardiogenic mesoderm specification from human embryonic stem cells. Mechanistically, EOMES-driven cardiomyocyte programming involves autocrine activation of canonical WNT signaling via WNT3 ligand, which must subsequently be shut down for cardiomyocyte maturation. |
EOMES gain- and loss-of-function in human ESCs, directed differentiation assays, WNT pathway inhibition/activation experiments |
Nature communications |
High |
29382828
|
| 2019 |
Eomes and Brachyury are required for mesoderm and definitive endoderm (ME) gene programs; cells deficient in these T-box factors retain pluripotency and default to neuroectoderm lineages even in the presence of TGF-β/Nodal and Wnt ME-inducing signals. Eomes and Brachyury bind ME enhancers and are required for their chromatin accessibility, whereas NE enhancers are pre-accessible. Eomes uniquely specifies anterior mesoderm and definitive endoderm, while Brachyury specifies caudal mesoderm. |
Conditional double KO of Eomes and Brachyury in mouse epiblast stem cells and embryos, ATAC-seq (chromatin accessibility), ChIP-seq, transcriptome analysis |
Nature cell biology |
High |
31792383
|
| 2019 |
TBR2 directly regulates Protocadherin 19 (PCDH19) expression, and PCDH19 mediates TBR2's role in coordinating clonal organization and preferential synapse development of excitatory neurons. Simultaneous PCDH19 expression rescues both neurogenesis and neuronal organization defects caused by TBR2 removal, placing PCDH19 as a direct downstream effector of TBR2 in cortical microcircuit assembly. |
Conditional TBR2 knockout, mosaic analysis with double markers (MADM), PCDH19 rescue experiments, electrophysiology in mouse cortex |
Nature communications |
High |
31477701
|
| 2019 |
GATA6 binds and cooperates with EOMES/SMAD2/3 to regulate expression of cardinal definitive endoderm genes in human pluripotent stem cells, as established by genome-wide ChIP studies. GATA6-null hPSCs fail to enter the DE lineage, an effect recapitulated in patient-derived cells, demonstrating that the GATA6-EOMES/SMAD2/3 axis is specifically required for human (but not mouse) pancreatic ontogeny. |
Genome-wide ChIP (GATA6, EOMES, SMAD2/3), GATA6 gene-edited and patient-derived hPSCs, directed differentiation toward DE and β-cells |
Stem cell reports |
High |
30629940
|
| 2019 |
Tbr2/EOMES directly represses Insm1 (an IP-genic transcription factor gene) and Pax6 (a key activator of Tbr2 transcription), and activates PN-specific genes such as Tbr1 by recruiting Jmjd3, a histone H3K27me3 demethylase that removes repressive epigenetic marks placed by polycomb repressive complex 2. |
ChIP-seq (Tbr2 direct targets), Jmjd3 co-IP/recruitment assay, Tbr2 conditional KO transcriptome analysis, H3K27me3 histone mark profiling |
Journal of anatomy |
Medium |
30677129
|
| 2019 |
EOMES is expressed in a rare subpopulation of spermatogonial stem cells (SSCs). Lineage tracing and busulfan challenge demonstrate these EOMES+ cells are SSCs contributing to steady-state spermatogenesis and regeneration following injury. PLZF regulates the proliferative activity of EOMES+ SSCs: EOMES+ SSCs have lower proliferation index in wild-type than in Plzf-/- mice, and are lost through proliferative exhaustion in Plzf-/- mice. |
Lineage tracing (Eomes-CreERT2), busulfan chemical injury model, RNAseq, single-cell RNAseq, Plzf knockout mice |
eLife |
High |
31149899
|
| 2019 |
EOMES interacts with RUNX3-bound enhancers and recruits BRG1 (a chromatin remodeling factor) to drive epigenetic reprogramming establishing the innate memory CD8+ T cell program. EOMES is found within chromatin-associated complexes containing BRG1, and the in vivo acquisition of the EOMES-dependent program is BRG1-dependent. |
Epigenomic profiling (ATAC-seq, H3K27ac ChIP-seq), co-immunoprecipitation identifying EOMES-BRG1 complex, BRG1 conditional KO, IL-4-driven innate memory model |
Nature communications |
High |
31341159
|
| 2020 |
Accumulation of CD226neg CD8+ T cells in tumors is driven by an antigen-specific mechanism involving EOMES. EOMES directly drives CD226 loss in CD8+ T cells, and anti-CD137 agonists stimulate Eomes-dependent CD226 downregulation that limits anti-tumor efficacy. CD226 loss is associated with reduced LFA-1 activation and altered TCR signaling. |
Flow cytometry in human/mouse tumors, Eomes conditional KO and overexpression, ChIP/ChIP-seq, anti-PD-1 and anti-CD137 treatment models |
Immunity |
High |
33053331
|
| 2020 |
AMPK activation by metformin decreases microRNA-107 expression, which enhances Eomesodermin expression, which in turn suppresses PDCD1 (PD-1) transcription in CD8+ T cells, promoting memory T cell formation via an AMPK-miR-107-Eomes-PD-1 pathway. |
In vitro metformin treatment, AMPK activation assay, miR-107 expression analysis, Eomes overexpression/knockdown, PD-1 promoter reporter assay, CAR-T tumor model |
Journal of immunology |
Medium |
32221038
|
| 2020 |
EOMES partners with PU.1 and MITF in a trimeric complex at genomic loci critical for osteoclast differentiation. Sequential ChIP confirmed co-occupancy. EOMES knockdown in myeloid precursors leads to osteopetrosis with decreased osteoclast differentiation and function in vitro and in vivo. |
Co-immunoprecipitation, sequential ChIP (re-ChIP), EOMES knockdown in myeloid precursors, in vivo mouse bone phenotype analysis |
iScience |
High |
30634169
|
| 2020 |
Eomes directly drives transcription of the prosurvival protein Bcl-2 in CD8+ T cells of low activation signal strength; this is induced at low signal intensity while T-bet is induced at higher signal intensity and suppresses Bcl-2. The Eomes/Bcl-2 axis preserves low-affinity CD8+ T cell clones in memory, maintaining clonal diversity. |
Eomes conditional KO, ChIP identifying Bcl-2 as direct Eomes target, affinity-based T cell activation models, clonal diversity analysis |
PLoS biology |
High |
32182234
|
| 2020 |
Stage-specific deletion of Eomes in mature NK cells (using tamoxifen-inducible Ncr1-targeted Cre) results in rapid loss of NK cells with particularly profound depletion of penultimately mature stage III NK cells, through increased apoptosis and impaired maturation from stage II precursors. Induced Eomes deletion also decreases NK cell cytotoxicity and abrogates in vivo rejection of MHC-class-I-deficient cells. |
Tamoxifen-inducible Ncr1-Cre × Eomes-flox conditional deletion, NK cell staging by flow cytometry, in vivo NK cell rejection assay, apoptosis assays |
Cell reports |
High |
32492428
|
| 2020 |
Nuclear LSD1 phosphorylated at serine 111 (nLSD1p) regulates EOMES nuclear dynamics via demethylation/acetylation switching of critical EOMES residues. EOMES co-exists with nLSD1p in PD-1+CD8+ T cells, and EOMES demethylation/acetylation is reciprocally expressed in immunotherapy-resistant versus responder patients. |
Novel antibodies detecting EOMES PTMs, co-expression analysis, nLSD1 inhibitor treatment, flow cytometry in patient samples and 4T1 mouse model |
Frontiers in immunology |
Low |
32612611
|
| 2021 |
The subcellular localization of T-bet and Eomes dictates their regulatory activity in exhausted T cells (TEXs): TEXs have a higher nuclear Eomes:T-bet ratio than memory T cells. T-bet and Eomes compete for the same DNA sequences including the Pdcd1 T-box; high nuclear T-bet strongly represses Pdcd1 transcription whereas low nuclear T-bet in TEX leads to dominant Eomes acting as a weaker repressor of Pdcd1. PD-1 blockade increases nuclear T-bet, restoring stronger Pdcd1 repression. |
Subcellular fractionation, nuclear/cytoplasmic T-bet and Eomes quantification, Pdcd1 reporter assays with T-bet/Eomes competition, LCMV chronic infection model, preclinical cancer models, human tumor samples |
Cell reports |
High |
33979613
|
| 2021 |
EOMES sequentially regulates NK cell development by driving early lineage specification and hallmark receptor/function induction in immature NK cells, while T-BET dominates in mature NK cells by inducing IL-12 responsiveness and repressing the cell cycle. ChIP of endogenous EOMES and T-BET shows strong overlap in DNA-binding targets with specificity mediated by differential co-factor recruitment and epigenetic changes during differentiation. |
Gene-modified mice enabling ChIP of endogenous EOMES and T-BET, ChIP-seq, ATAC-seq, Eomes/T-bet conditional KO mice, NK cell staging |
Nature communications |
High |
34521844
|
| 2021 |
Eomes controls the follicular location of CD8+ regulatory T cells (CD8+ Tregs), while TGF-β receptor signaling maintains their regulatory identity. Simultaneous disruption of TGF-β receptor and Eomes in T cells causes lethal autoimmunity due to specific loss of CD8+ (but not CD4+) Tregs. |
Conditional double KO of TGF-β receptor and Eomes in T cells, autoimmunity phenotype analysis, CD8+ vs CD4+ Treg quantification, tissue localization |
The Journal of experimental medicine |
High |
32991667
|
| 2021 |
EOMES directly bound the promoter of T-cell immunoglobulin and ITIM domain (TIGIT) and positively regulated TIGIT expression on patient-derived T cells. siRNA-mediated depletion of Eomes reversed functional defects (cytokine production and killing capacity) in Eomes+T-betlow CD8+ T cells from AML patients. |
ChIP (EOMES binding to TIGIT promoter), siRNA knockdown, flow cytometry functional assays in patient-derived AML T cells |
Cancer research |
Medium |
30709927
|
| 2021 |
Eomes is identified as a key factor instructing early bifurcation of circulating and tissue-resident (TRM) CD8+ T cell lineages: Hobit+ TRM precursors form during the effector phase, and Eomes regulates the early commitment to residency versus circulation. |
Hobit reporter/deleter mice, Eomes conditional KO, adoptive transfer of Hobit+ effector cells, transcriptional profiling of TRM precursors |
Science immunology |
Medium |
34417257
|
| 2021 |
EOMES-deficient CD8+ T cells show impaired expansion and decreased CLL tumor control in vivo. EOMES is therefore essential for CD8+ T cell expansion/maintenance required for adaptive immune control of CLL. |
Eomes conditional KO in CD8+ T cells, Eµ-TCL1 CLL mouse model, tumor control assay, flow cytometry |
Leukemia |
Medium |
33731848
|
| 2021 |
Eomes directly bound the transcriptional regulatory regions of the key inhibitory receptors PD-1, CTLA-4, and CD39 in CD8+ T cells from hepatocellular carcinoma tumors; lower EOMES levels in tumor-infiltrating CD8+ T cells contributed to overexpression of these inhibitory factors. |
ChIP (EOMES binding to PD-1, CTLA-4, CD39 regulatory regions), flow cytometry in patient tumor-infiltrating lymphocytes |
Journal of cellular and molecular medicine |
Medium |
33325636
|
| 2021 |
Eomes directly controls expression of T cell exhaustion gene Havcr2 (Tim-3) through high-level Eomes binding to regulatory genomic loci, and Eomes may compete with T-bet at shared regulatory genomic loci to antagonize T-bet functions. Integrated RNAseq and ChIPseq in Eomes-overexpressing T cells revealed direct Eomes transcriptional control of exhaustion genes. |
ChIP-seq (Eomes binding), RNAseq in Eomes-overexpressing T cells, Eomes heterozygous deletion in tumor model, Havcr2 direct target validation |
Frontiers in immunology |
Medium |
30619337
|
| 2019 |
Extrapituitary prolactin (PRL) produced by B cells and MHC class II+ myeloid cells in late EAE lesions induces Eomes+ CD4+ T (Th) cells from naïve T cells ex vivo in an MHC class II-dependent manner. Blocking PRL production (bromocriptine or Zbtb20-specific siRNA) significantly reduced Eomes+ Th cells in the CNS and ameliorated late EAE clinical signs. |
EAE mouse model, PRL blocking (bromocriptine, Zbtb20 siRNA), ex vivo PRL stimulation, anti-MHC class II antibody blockade |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
31570595
|
| 2022 |
Eomes exhibits context-specific roles in intestinal tissue-resident memory CD8+ T cells (TRM): while Eomes represses TRM formation in some tissues, it supports maintenance of established TRM cells in the small intestine but not in the colon, revealing tissue-compartment-specific regulatory functions. |
Eomes conditional KO, TRM isolation from lamina propria and epithelial compartments of small intestine and colon, transcriptomic and epigenetic profiling |
Immunity |
High |
36580919
|
| 2023 |
On a genome-wide scale, Eomes and Brachyury binding overlaps at target gene promoters but shows specificity for distal enhancer regions conferred by differences in Tbx DNA-binding motifs. Eomes antagonizes Brachyury gene regulatory functions in coexpressing cells during early gastrulation via these differential enhancer binding preferences, ensuring proper sequence of anterior mesoderm/DE followed by posterior mesoderm specification. |
ChIP-seq (endogenous Eomes and Brachyury), Eomes/Brachyury single and double KO in mouse embryos and stem cells, transcriptome analysis, enhancer motif analysis |
Developmental cell |
High |
37633271
|
| 2023 |
Deletion of T-BET and EOMES in primary human NK cells using CRISPR/Cas9 compromises in vivo antitumor response, NK cell proliferation and persistence, and cytokine responses. T-BET and EOMES deletion causes CD56bright NK cells to acquire an innate lymphoid cell precursor-like (ILCP-like) profile with increased RORC and AHR (ILC3-associated TFs), demonstrating that T-box TFs suppress alternative ILC lineages in mature NK cells. |
CRISPR/Cas9 deletion in primary human NK cells, in vivo xenograft tumor models, single-cell RNA-seq, TF expression analysis |
The Journal of clinical investigation |
High |
37279078
|
| 2023 |
Eomes expression in murine CD4+ T cells is sufficient to induce IL-10 expression and, together with T-bet, promotes a cytotoxic effector profile (Prf1, Gzmb, Gzmk, Nkg7, Ccl5) while repressing alternative cell fates (Th2, Th17). The Eomes-driven transcriptional program in CD4+ T cells only partially overlaps with that of T-bet. |
Novel genetic approach to enforce Eomes expression in CD4+ T cells, transcriptomic profiling (RNA-seq), cytokine/effector molecule measurement by flow cytometry |
Frontiers in immunology |
Medium |
36756120
|
| 2024 |
EomeshiNKneg cells in the bone marrow (lineage-negative, NK receptor-negative, Eomes-expressing) are the bone marrow precursors to classical NK cells. Transfer of EomeshiNKneg cells into Rag2-/-Il2rg-/- recipients generates functional NK cells capable of preventing metastatic disease, while PLZF+ ILC precursors generate ILC1s, ILC2s, and ILC3s lacking cytotoxic potential—establishing that NK and ILC1 lineages diverge early in development and that Eomes marks the NK-committed precursor. |
Single-cell RNA-seq, flow cytometry, adoptive transfer into immunodeficient recipients, metastasis prevention assay |
Nature immunology |
High |
38871999
|
| 2013 |
EOMES interacts with CREBBP (CBP) as shown by immunoprecipitation, and EOMES down-regulates interferon tau (IFNT) gene transcription in bovine/ovine trophoblast cells. Transient transfection reporter assays showed EOMES suppresses IFNT promoter transactivation. Uterine flushing from pregnant animals increases EOMES expression in bovine trophoblast CT-1 cells specifically in co-culture with uterine epithelial cells. |
Co-immunoprecipitation (EOMES-CREBBP), transient transfection reporter assay, real-time PCR, CT-1/uterine epithelial cell co-culture |
Molecular reproduction and development |
Medium |
23606646
|